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ABSTRACT The surprising observation that pressures of the order of 150 atmospheres can restore consciousness to an
anesthetized animal has long been central to theories of the molecular mechanisms underlying general anesthesia. We have
constructed a high-pressure gas chamber to test for "pressure reversal" of the best available protein model of general anesthetic
target sites: the pure enzyme firefly luciferase, which accounts extremely well for animal potencies (over a 1 00,000-fold range). We
found no significant pressure reversal for a variety of anesthetics of differing size and polarity. It thus appears that either firefly
luciferase is not an adequate model for general anesthetic target sites or that pressure and anesthetics act at different molecular
sites in the central nervous system.
INTRODUCTION
The discovery (Johnson and Flagler, 1950, 1951) of the
pressure reversal of general anesthesia has long been
thought to provide an important clue as to how general
anesthetics act (Lever et al., 1971; Halsey and Wardley-
Smith, 1975; Franks and Lieb, 1982; Dluzewski et al.,
1983; Miller, 1985). Indeed, many workers have argued
that pressure and anesthetics act antagonistically at the
molecular level and therefore, because pressure can
only act (at constant temperature) by reducing volume,
anesthetics must be exerting their effects by increasing
volume. Such arguments led to the critical volume
hypothesis (Miller et al., 1973), which postulates that a
critical expansion of some crucial target in the central
nervous system results in the state of general anesthesia,
which can then be reversed by pressure compressing the
target back to its original functional state. More complex
variants of the critical volume hypothesis, involving
multiple targets, have also been proposed (Halsey et al.,
1978). Another hypothesis (Franks and Lieb, 1982),
which also assumes that pressure and anesthetics act at
the same molecular sites, explains the animal data
equally well: the volume changes which occur when
general anesthetics bind to their targets are irrelevant to
the actual mechanism of anesthesia but are nonetheless
sufficient to account for pressure reversal, because
increasing pressure favors dissociation of the anesthetic
molecule from its targets. An alternative to these ideas is
that anesthetics and pressure act at different molecular
targets and that pressure reversal is a fortuitous combi-
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nation of a generalized stimulation by pressure overcom-
ing the depression brought about by anesthetics (Winter
et al., 1976; Tarasiuk et al., 1991). Support for this view
comes from the fact that although anesthetic potencies
are quite similar for a wide range of animals, the
pressures needed to reverse anesthesia vary consider-
ably from animal to animal (Franks and Lieb, 1982) and,
in some animals, anesthesia cannot be reversed by
pressure at all (Simon et al., 1983; Smith et al., 1984).
The problem in testing such ideas is that the molecu-
lar target sites underlying general anesthesia have yet to
be identified. In recent years (Richards, 1980; Franks
and Lieb, 1982; Dluzewski et al., 1983; Miller, 1985;
Franks and Lieb, 1987), attention has been focussed on
two extreme alternative types of target sites: lipids and
proteins. The traditional view has been that anesthetics
act by dissolving in lipid regions of nerve membranes
and so perturbing their structure or dynamic properties
(e.g., fluidity) that the normal functioning of membrane
proteins (such as ion channels) is compromised. Al-
though criticized (Franks and Lieb, 1978; Richards et
al., 1978; Franks and Lieb, 1982; Franks and Lieb, 1987)
on quantitative grounds (effects on lipid bilayers are
generally extremely small at surgically relevant anes-
thetic concentrations), lipid models have the attraction
of accounting for pressure reversal, at least qualitatively,
because a number of anesthetic-induced perturbations
of lipid bilayers can be reversed by high pressures
(Franks and Lieb, 1982; Dluzewski et al., 1983; Miller,
1985). The pressures required, however, are generally
much lower than those needed to reverse the effects of
general anesthetics in animals (Boggs et al., 1976;
Biophys. J. © Biophysical Society
Volume 60 December 1991 1309-1314
0006-3495/92/12/1309/06 $2.00 13091309/06 1309
Mountcastle et al., 1978; Finch and Kiesow, 1979;
Kamaya et al., 1979; Mastrangelo et al., 1979).
The alternative hypothesis is that general anesthetics
act simply by binding directly to particularly sensitive
proteins and modifying their function (Franks and Lieb,
1978; Richards et al., 1978; Richards, 1980; LaBella,
1981; Franks and Lieb, 1982). The strongest support for
this view comes from recent observations (Franks and
Lieb, 1984) that the lipid-free protein firefly luciferase
can be competitively inhibited by a diverse range of
general anesthetics at concentrations which are almost
identical to those which induce general anesthesia in
animals, over a 100,000-fold range of concentrations.
Moreover, the abrupt cutoffs in anesthetic potency
which are observed with long-chain compounds in ani-
mals are mimicked by similar effects on the firefly
enzyme (Franks and Lieb, 1985; Moss et al., 1991).
Thus firefly luciferase is probably the best available
protein model of general anesthesia. If anesthetics and
pressure do indeed act by direct antagonism at the same
protein target sites, one would expect the anesthetic
inhibition of firefly luciferase to be overcome by high
pressure. We decided to test this prediction. To do this,
however, it was first necessary to design and construct a
rapid-mixing system suitable for assaying the luciferase
enzyme at high pressures. The system had to be able to
perform the multiple assays required for kinetic analysis
in a reasonable amount of time, because the luciferase
enzyme inactivates slowly and spontaneously with time
at room temperature. Furthermore, it was designed to
operate using helium as the pressurizing agent. This was
because much of the available data (including all of the
data for mammals) has been obtained using helium
rather than hydrostatic pressure, and the physiological
effects of helium and hydrostatic pressure are not always
equivalent (Macdonald and Wann, 1978; Dodson et al.,
1985).
MATERIALS AND METHODS
Purification of luciferase enzyme
Details of the procedures used to obtain pure ( - 99%) preparations of
the firefly (Photinus pyralis) luciferase enzyme have been published
elsewhere (Branchini et al., 1980; Franks and Lieb, 1986). The highly
purified enzyme was stored as a stock solution in 0.4 M ammonium
sulphate, 1 mM EDTA, pH 7.8 at 4°C. D-luciferin, desiccated firefly
lanterns and ATP (grade I) were purchased from Sigma Chemical
Company (St. Louis, MO). N-Glycylglycine and MgSO4 were obtained
from BDH, Dagenham. All reagents used were of the highest purity
available from the above suppliers and were used without further
purification.
High-pressure rapid-mixing chamber
The high-pressure chamber we constructed is shown schematically in
Fig. 1 A. The control reaction was initiated by rapidly injecting a small
amount of solution containing ATP and the enzyme from a glass
syringe into a reaction vial containing a solution of the substrate firefly
luciferin. Before the injection, the vial could be continually stirred, so
as to allow equilibration of the solution with the helium pressurizing
gas. The chamber was fabricated from a single piece of type 303/S21
stainless steel, and it was rated for a maximum working pressure of 300
atm. The luciferase reaction was initiated by operating a high-torque
900 rotary solenoid which turned a lead screw (double-threaded, 2-mm
pitch) and advanced a polytetrafluoroethylene (PTFE) block attached
to the plunger of a 5-ml glass syringe. This syringe held a buffered
solution containing the luciferase enzyme, oxygen, ATP and, when
required, anesthetic. The injected solution (160 ±l) was delivered into
a small glass reaction vial which contained 500 ,ul of a buffered solution
of magnesium sulfate and the substrate luciferin. All solutions were
buffered at pH 7.8 using 25 mM N-glycylglycine. Light from the
reaction passed through a sapphire window (6.4 mm thick) before
being focussed by a lens and directed to a sensitive photomultiplier via
a silvered Mylar mirror (to protect the photomultiplier tube in the
advent of a failure of the sapphire window). The glass reaction vial was
one of twenty, mounted on a rotary carousel driven by a stepper motor.
Each vial was located in a gear wheel which rotated the vial about its
own axis several times for each circuit of the carousel. Stirring bars in
each vial allowed rapid equilibration of the solutions in the vial with
the high-pressure helium gas in the chamber. A system of micros-
witches ensured accurate positioning of each vial under the injection
syringe. The design was such that none of the moving parts in the
chamber required lubrication. The chamber pressure was monitored
continuously using a piezoelectric sensor, and the temperature was
recorded using a thermocouple mounted in a dummy sample vial (not
shown in the figure) containing 500 ,ul of water. The signal from the
photomultiplier was passed through a current-voltage converter and
stored on a digital storage oscilloscope and chart recorder. Luciferase
activity was taken as the peak light intensity, i.e., the maximum rate of
photon emission (Franks and Lieb, 1984; Moss et al., 1991).
RESULTS AND DISCUSSION
We first determined the effects of high pressures of
helium on the activity of the luciferase enzyme in the
absence of anesthetics. Fig. 1 B shows the control re-
sponse at ambient pressure (1 atm helium), and Fig. 1 C
shows the response at elevated (150 atm) pressure. We
found that the peak in the light output did not change
significantly over the range of helium pressures between
1 to 150 atm. Furthermore, double-reciprocal plots
obtained by measuring reaction velocities at different
luciferin concentrations (see inset to Fig. 2) showed that
the Km for luciferin was independent of pressure (see
Fig. 2). Thus, there were no significant changes with
pressure in either the substrate-binding reaction or the
subsequent catalytic steps. The absence of any signifi-
cant change in control luciferase activity with pressure
rules out one a priori possible mechanism of pressure
reversal. Pressure might simply increase enzyme activity
1310 Biophysical Journal Volume 60 December 1991Volume 60 December 19911310 Biophysical
*._
0
0
0
cL
0
.LCL
._%
._
0
0
>4
0)
0
Co
0
L.,
CL
100
50
0
100
50
0
FIGURE 1 (A) A schematic drawing of the high-pressure chamber used for the luciferase experiments. See text for details. (B) A typical record
from the luciferase reaction at 1 atm helium. (C) A typical record from the luciferase reaction at 150 atm helium. In both cases, activity is expressed
as a percentage of the control activity at 1 atm helium. The final reagent concentrations were 10 nM luciferase enzyme, 2 mM ATP, 6.7 mM
magnesium sulfate and 10 ,uM luciferin in 25 mM N-glycylglycine buffer at pH 7.8. The pressure was applied using helium gas (BOC, 99.99% pure)
at a rate of - 10 atm min-'. Usually 10 min were allowed to achieve equilibration, at which time the sample temperature was generally within 1°C of
the ambient temperature, which was typically 20°C.
to compensate for the anesthetic inhibition. In the case
of the luciferase enzyme, however, the overall volume of
activation for the reaction is evidently too small for this
to be a significant effect.
We then went on to determine the effects of pressure
on the enzyme in the presence of a variety of general
anesthetic agents to test the possibility that the binding
equilibrium between the anesthetics and enzyme is
altered at high pressure, due to a change in the volume
of the system upon binding. For these experiments, we
introduced anesthetics into the ATP injection syringe so
that any pressure reversal that might be observed could
not be due to a simple redistribution of anesthetics
between the aqueous solution and the gas phase in the
chamber. This was important because we have previ-
ously shown (Franks and Lieb, 1982) that much of the
pressure reversal observed with gases for mice (Miller et
al., 1978) can be accounted for simply in terms of the
expected changes in solubility from the gas phase.
Pressure-reversal data (Halsey et al., 1978; Miller and
Wilson, 1978) for intravenous agents, however, are not
so easily explained because unreasonably large binding
volumes would be required to account for pressure
reversal in terms of displacement from the target sites.
Our initial results with methoxyflurane, however,
showed that the anesthetic-inhibited luciferase reaction
was not significantly affected when pressure was applied,
indicating that any pressure effects on anesthetic bind-
ing must be small (see Fig. 3). Because anesthetics
inhibit the luciferase enzyme by competing for the
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FIGURE 2 The Km for luciferin does not change significantly with
pressure. At each pressure, the Km was determined using double-
reciprocal plots (inset) over a range of luciferin concentrations. The
error bars represent standard errors. (Inset) A typical double-
reciprocal plot (at 1 atm). Each point represents the mean of at least
three enzyme assays, and the standard errors are smaller than the size
of the symbols. The double-reciprocal line was fitted by the method of
weighted least squares, with the errors in Km determined as described
in detail elsewhere (Curry et al., 1990).
substrate luciferin, any changes in anesthetic binding
constants would be most accurately quantified by measur-
ing changes in the apparent Km for luciferin (rather than
in the anesthetic/enzyme dissociation constant Ki, be-
cause a determination of Ki inevitably includes the
random error in the Michaelis constant Km.) We there-
fore measured the apparent luciferin Km as a function of
helium pressure in the presence of anesthetics.
The results of these experiments were uniformly
negative. There was no significant change with pressure
in the apparent Km for luciferin (KaPP) and hence
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FIGURE 3 Anesthetic inhibition of the luciferase reaction is not
reversed by high pressure. The data show the light output from the
luciferase reaction in the presence of 0.53 mM methoxyflurane,
expressed as a percentage of the activity in the absence of anesthetic
and at 1 atm helium pressure. Responses at (A) 1 atm and (B) 150 atm.
The final luciferin concentration was 10 aM.
(because the control Km was constant) in the binding of
the anesthetics to the enzyme. This is shown in Fig. 4 for
the volatile general anesthetics methoxyflurane and
chloroform as well as for the aliphatic alcohol n-octanol.
We obtained similar negative results (not shown) with
n-hexanol (0-1.5 mM) benzyl alcohol (0-4 mM), n-de-
canol (0-15 ,uM), and the local anesthetic benzocaine
(0-64 ,uM), although with the latter two agents we did
observe a small increase in potency with pressure. The
small increases in the potencies of n-decanol and ben-
zocaine presumably reflect small increases in the bind-
ing of these relatively large agents. Whereas this effect
may be interesting, it is in the opposite direction to that
needed to account for pressure reversal in terms of
displacement of anesthetics from their target sites
(Franks and Lieb, 1982). We also confirmed (for the
case of n-decanol) that there was no change with
pressure in the stoichiometry of anesthetic binding to
the enzyme. Thus, for molecules of varying size and
polarity, we observed no evidence of any significant
degree of pressure reversal.
Our results are clear cut: there is no significant
pressure reversal of the anesthetic inhibition of firefly
luciferase. This leaves open two alternatives: either (a)
firefly luciferase is a poor model for the target sites
underlying general anesthesia, perhaps accounting for
anesthetic inhibition but not for pressure reversal, or (b)
firefly luciferase is a good model for general anesthetic
target sites, but pressure reversal of general anesthesia is
due to pressure acting at different molecular sites than
those which are affected by anesthetics (Winter et al.,
1976; Tarasiuk et al., 1991). As to the first alternative, it
is of course possible that a protein will be found which
can account for both anesthetic potencies and pressure
reversal. Indeed, it should be remembered that the
discovery of pressure reversal in animals (Johnson and
Flagler, 1950, 1951) was preceded by a report (Johnson
et al., 1942) of pressure reversal in luminescent bacteria,
and it might be thought that the bacterial luciferases
which catalyze the light-emitting reactions are good
candidates. However, pressure reversal of anesthetic
inhibition of bacterial luminescence does not occur for
some agents (e.g., sodium barbital), is marginal for
others (e.g., diethyl ether), and even in favorable cases
(e.g., chloroform) is modest at pressures (150 atm)
which produce reversal in animals (Johnson et al., 1942).
Furthermore, while it has been reported (Strehler and
Johnson, 1954) that a crude cell-free extract can exhibit
qualitatively similar effects to those found with intact
cells, pressure reversal has yet to be demonstrated using
a purified bacterial luciferase. This is important in view
of a recent finding (Curry et al., 1990) that the purified
bacterial luciferase from Vibrio harveyi is remarkably
insensitive to a number of general anesthetics, which
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associated standard error was determined using a double-reciprocal
plot (see inset toA), as described in the legend to Fig. 2. KmPP is simply
related to the dissociation constant KH for the anesthetic (Franks and
Lieb, 1984) but can be determined more accurately than Ki itself. The
final anesthetic concentrations were 0.53 mM methoxyflurane, 2 mM
chloroform and 0.776 mM n-octanol, which all reduced the enzyme
activity to roughly 25% of the control.
suggests that the anesthetic and pressure sensitivities of
purified enzymes may be very different to those of intact
bacterial cells. Whether or not a protein will be found
that is both sensitive to a wide range of anesthetics and
whose inhibition is reversed by high pressure remains to
be seen.
The second alternative, that anesthetics and pressure
act at different sites, has always been a possibility that
had to be taken seriously (for a review, see Wann and
Macdonald [1988]). When complex neuronal responses
are considered, there are cases where pressure does act
antagonistically (Angel et al., 1980) and other cases
where it does not. For example, it has very recently been
shown (Tarasiuk et al., 1991) that the depressive effects
of a barbiturate on the rhythmic activity of a medullary
respiratory center were mimicked, rather than antago-
nized, by high pressures of helium. At the cellular level
pressure has been shown to partially reverse the effects
of anesthetics on axonal conduction (Kendig et al., 1975;
Roth et al., 1976). Strikingly, however, the effects of
anesthetics and pressure on synapses, generally re-
garded as the most likely target site for anesthetics
(Pocock and Richards, 1991), have been shown to be
synergistic rather than antagonistic (Kendig et al., 1975;
Kendig and Cohen, 1976; Wann et al., 1980; Wann and
Macdonald, 1988). Our present results with the firefly
luciferase enzyme, one of the best molecular models for
anesthetic target sites, adds to this body of evidence that
calls into question the usual assumption that pressure
and anesthetics act at the same molecular target sites.
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